Medical Devices & Surgical Technology Week articles from March 2004

Medical Devices & Surgical Technology Week archives from March 2004

Stereomammography may be able to distinguish overlapping tissue from masses.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Stereoscopic imaging mammography may be able to visualize spatial distributions of microcalcifications and to determine overlapping tissues from actual masses, researchers say. According to a study...

Medical device regulation complicated by multiple agency involvement.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Medical device regulation in the United States is complicated by multiple agency involvement. "The pace of medical technological development shows no sign of abating. Analyzing the effect of major...

Hand-held echocardiography devices feasible for LVH testing.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Hand-held echocardiography devices are suitable for use in community-based LVH screening. "Left ventricular (LV) hypertrophy (LVH) confers increased cardiovascular risk on patients with...

Video-assisted thoracoscopy is useful for preoperative staging NSCLC.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Study affirms the utility of video-assisted thoracoscopy in the preoperative staging of T3, T4, and T doubtful non-small cell lung cancer (NSCLC), as well as N2 in the surgical exploration of lymph...

Death rates for certain complex surgeries lower at teaching hospitals.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Death rates for some complex gastrointestinal surgical procedures are lower at teaching hospitals than at non-teaching hospitals, study findings show. Teaching hospitals are responsible for the...

Early results of injection laryngoplasty with collagen are satisfactory.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- A method of injecting cadaveric collagen to improve glottic closure in patients with vocal cord paralysis proves comparable to the gold standard procedure, in early results. "Medialization...

Microsurgery is necessary for creating arteriovenous fistulas in children.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Researchers report a 60% patency rate after 10 years for microsurgically created arteriovenous fistulas (AVF) in children. According to recent research from France, "Microsurgery for angioaccess in...

FDA approves Syneron Aurora for dermatological use.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Syneron Medical, Ltd., and its North American subsidiary Syneron, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted 510K marketing clearance to Syneron's Aurora AC system for...

Disease threatens to blind 12 million Americans.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- While many people have never heard of age-related macular degeneration (AMD), the disease is ravaging the sight of at least 12 million Americans, causing their vision to become spotty, distorted, or...

Final efficacy results awaited as ALS trial of Ikomio moves forward.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- ExonHit Therapeutics, a privately held drug discovery company, announced it has received recommendation by an independent Data Safety Monitoring Board (DSMB) to continue its clinical trial for Ikomio, a...

New blood-conserving device has no effect on postoperative anemia.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Although a new blood conservation device significantly reduced iatrogenic blood loss in intensive care unit patients, it did not affect the fall in hemoglobin levels. According to published...

Data presented demonstrate enduring benefits of TMR.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- CardioGenesis Corporation (CGCP), provider of angina-relieving Transmyocardial Revascularization (TMR) and Percutaneous Myocardial Revascularization (PMR), announced that new, conclusive 5-year data...

Phase III trial initiated to explore use of Humira.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories (ABT) announced the initiation of a global phase III study evaluating the potential of Humira (adalimumab) in treating ankylosing spondylitis. Ankylosing spondylitis (AS), or...

ISO certification granted for continuous positive airway pressure devices.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- InnoMed Technologies announced that it has received the International Standards Organization (ISO) Quality System Certification. The company's facility in Greensburg, Pennsylvania, has received the...

New embryology lab opens in Chicago.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Fertility Centers of Illinois (FCI) has opened a new in vitro fertilization (IVF) facility to serve the growing needs of IVF patients in the Chicago, Illinois, area. The FCI River North Center is...

Hanks balanced salt solution is best for transporting avulsed teeth.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Researchers determine that Hanks balanced salt solution (HBSS) is the best solution for transporting avulsed teeth to the dentist; low-fat milk with ice added is the next best alternative. "Many...

"Camera pill" may be useful in diagnosing conditions in the esophagus.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Capsule endoscopy, the "camera pill" device already shown to be effective in diagnosing conditions of the small intestine, may also be an effective noninvasive alternative for diagnosing conditions of...

Company receives first patent for high-security genetic-banking system.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- First Genetic Trust, Inc., announced that it has received the first patent to be issued for an e-genetic banking system and supporting technology. The U.S. Patent and Trademark Office issued patent...

Alkaline comet assay predicts bladder cancer cell radiosensitivity.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Bladder cancer cell radiosensitivity can be predicted using the alkaline comet assay (ACA), which can potentially identify nonresponsive tumors, researchers say. "In the UK, the two main treatments...

Procleix Ultrio Assay clinical trials commence.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Chiron Corporation (CHIR) announced that the U.S. clinical trials of the Procleix Ultrio Assay on the Procleix Tigris system have started in San Diego, California, under an investigational new drug. ...

FDA provides marketing clearance for magnesium assay.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Abaxis, Inc., (ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced that it has received U.S. Food and Drug Administration (FDA) market clearance for its...

MRI and CT can be used to diagnose intracerebral hematoma.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- CT and MRI are useful in diagnosing intracerebral hematomas, but angiography may be needed to determine whether there is an intracranial vascular malformation. According to published research from...

Genetic patterns were stable in human malignant glioma xenografted in nude mice.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Studying subcutaneous xenografts in nude mice is promising for analysis of the molecular profile of malignant astrocytoma and oligodendroglioma, researchers report. "In order to develop preclinical...

FDA accepts NDA with priority review for RSR13.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Allos Therapeutics, Inc., (ALTH) announced that the Division of Oncology Drug Products at the U.S. Food and Drug Administration (FDA) has accepted for review the company's New Drug Application (NDA)...

Full-field breast ultrasound complements mammography.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Siemens Medical Solutions Ultrasound Division and U-Systems, Inc., a developer of full field breast ultrasound (FFBU), have entered into an agreement where Siemens' provides the ultrasound engine of the...

Sarcomas of the breast prone to relapse unless wide surgical margains attained.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Sarcomas are rare lesions in the breast and treatment should focus on surgical removal with wide margins. "Breast sarcomas are rare lesions that can be derived from any of the mammary stromal...

New estrogen inhibitor in phase II development.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics, Inc., announced that it has obtained exclusive North American development, marketing and commercialization rights to the developmental pharmaceutical product, TamoGel...

Biotech begins the year with a bang.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- "Bolstered by good news at the clinic as well as the announcement of a number of promising collaborations, biotech's appeal on Wall Street grew significantly stronger in January," said G. Steven...

Diagnostics company goes public.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Motion DNA Corp. (MOTD) became a publicly traded company January, 30, 2004. The board of directors unanimously agreed to take the company public on the OTC in a meeting held January 19, 2004. ...

Inspection of drug-eluting stent facility completed; finances reported.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Boston Scientific Corporation (BSX) announced that an inspection team from the U.S. Food and Drug Administration (FDA) has completed its inspection of the company's drug-eluting stent manufacturing...

Laser company delisted from NASDAQ; shares to trade on Pink Sheets.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Lumenis, Ltd., (LUME) has received notice that the company's ordinary shares were to be delisted from the NASDAQ National Market (NASDAQ) prior to the market opening on Friday, February 6, 2004. ...

Medamicus officially changes its name.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- As previously announced, Medamicus, Inc., (MEDM) has changed its name to Enpath Medical, Inc. The company's new NASDAQ ticker symbol is NPTH. The name Enpath reflects the company's mission "to...

FLAIR-MRI can detect abnormal hyperintensity within the subarachnoid space.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- FLAIR-MRI can show central nervous system (CNS) abnormalities as areas of hyperintensity, but can also show artifacts. According to recent research from Japan, "A variety of CNS diseases are...

Fourth phase II trial initiated for new stem cell transplantation drug candidate.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced the initiation of its fourth phase II clinical trial to evaluate AMD3100 as a new stem cell transplantation drug candidate for cancer patients. Clinical data to date...

Indiana's mega-million proton therapy cancer center welcomes its first patients.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- A medical center at Indiana University that cost $40 million and has been 10 years in development has begun treating its first patients, using proton beams to destroy inoperable cancerous tumors and...

ISOL myocyte apoptosis screening leads to fewer false-positive results.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- ISOL screening for myocyte apoptosis leads to fewer false-positive results than ISEL or TUNEL testing. In a recent study, scientists in Italy "assessed the efficiency of detecting myocyte apoptosis...

Medium perfusion enables functional cardiac tissue engineering.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Medium perfusion enables the engineering of functional cardiac tissue. Scientists in the United States "hypothesized that functional constructs with physiological cell densities can be engineered in...

Transcatheter repair of traumatic ventricular septal defect reported.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Successful transcatheter-based repair of extensive ventrical septal trauma has been reported. Cardiologists in the United States reported "the first successful transcatheter closure of a large...

Immersion achieves the second of three milestones in deal with Medtronic.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Immersion Corp. (IMMR), a developer and licensor of touch feedback technology, announced the achievement of the second of three significant milestones under development and licensing agreements with...

PET can elucidate regional sympathetic function during heart disease.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Positron emission topography (PET) imaging can be used to elucidate the effects of heart disease on regional sympathetic function. In a study from the United States, PET "was used to measure global...

HPV, chromosome aberrations correlate with transition to microinvasive carcinoma.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Integration of human papillomavirus (HPV) 16/18 DNA is an important event in the transition of cervical intraepithelial neoplasia (CIN I, II, and III) to microinvasive carcinoma. "Cervical...

In situ hybridization techniques may be able to detect HPV.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- High-risk human papillomaviruses (HPVs) might be detected by sensitive in situ hybridization techniques. "Human papillomaviruses are accepted as a necessary cause of cervical neoplasia. However,...

Publication points to increasing use of HPV testing in cervical cancer screening.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- The first consensus guidance on the most effective way to use HPV DNA testing for cervical cancer screening has been published in the February issue of Obstetrics & Gynecology, announced Digene Corp....

FDA approves Spiriva HandiHaler.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration (FDA) has approved Spiriva HandiHaler (tiotropium bromide inhalation powder) for the long-term,...

Fine needle aspiration is effective as a diagnostic tool in chronic tonsillitis.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Fine needle aspiration (FNA) of tonsillar tissue can identify the bacterial organism and allow appropriate antibiotic therapy, researchers say. "Fine needle aspiration of the tonsil as a diagnostic...

Axeda DRM software licensed for proactive remote service.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- The Diagnostics Division of Bayer HealthCare, LLC, a member of the Bayer Group (BAY), and Axeda Systems, Inc., (XEDA), a provider of device relationship management (DRM) enterprise software and...

BIS technology to be integrated across monitoring product line.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Aspect Medical Systems, Inc., (ASPM) has entered into a multiyear, worldwide development and licensing agreement with Draeger Medical Systems, Inc., the Patient Monitoring subsidiary of Draeger Medical...

Biotech companies sign licensing deal for protein therapeutics development.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Chromos Molecular Systems, Inc., (CHR) and AviGenics, Inc., announced that they have signed a license agreement under which AviGenics has acquired exclusive rights to Chromos' ACE System to generate...

Co-brand partnership agreement signed with 3M.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Alltracel Pharmaceuticals, plc, (AP.L) announced a material supply, technology transfer and co-brand partnership program with the Health Care division of 3M (MMM), the global diversified technology...

Companies ink agreement to develop MicroPyramid-based vaccine delivery.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- NanoPass Technologies, Ltd., has signed an agreement with GlaxoSmithKline's Biopharmaceutical Centre of Excellence for Drug Discovery (GSK) to develop NanoPass' MicroPyramid technology for the delivery...

Deal signed with Amylin Pharmaceuticals to develop Omniclonal antibodies.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE) has entered into a discovery collaboration with Amylin Pharmaceuticals, Inc., under which Biosite intends to develop Omniclonal antibodies for targets provided by Amylin. ...

Device firm to develop immunochromatographic rapid test devices.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- AspenBio, Inc., (APNB) announced that it has created a Lateral Flow Division for the development, manufacturing and distribution of immunochromatographic rapid test devices. The devices determine...

Genetronics announces strategic alliance.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Genetronics Biomedical Corp. (GEB) announced an agreement with RMR Technologies, LLC, (RMR), where Genetronics may commercialize RMR's electroporation methods and devices on a worldwide exclusive basis....

Integrated BioPharma sub, Purdue gene-transfer study results published.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Scientists at NuCycle Therapy, a wholly owned subsidiary of Integrated BioPharma, Inc., (INB), teamed with researchers at Purdue University in a 2-year study funded by the U.S. National Institute of...

Marketing agreement signed for promotion of aspergillus test.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Bio-Rad Laboratories, Inc., (BIO; BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, announced that it has entered into a marketing agreement...

Partnership to develop new treatment for tropical disease.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Roche and AEterna Laboratories, Inc., (AEL; AELA) announced a partnership for the marketing in Brazil of Impavido (Miltefosine), the breakthrough oral therapy of leishmaniasis. The agreement was...

Questra to provide remote monitoring for medical instruments.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Questra, a maker of remote diagnostics for medical instruments, announced that GE Healthcare (formerly GE Medical Systems), a global leader in medical technology and information systems with more than...

Supply agreement signed with Hepatotech for preservation solutions.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- BioLife Solutions, Inc., (BLFS) announced that it has signed a multiyear supply agreement with Pittsboro, North Carolina-based Hepatotech, Inc., a privately held manufacturer and distributor of...

PEECH trial reaches enrollment target.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Vasomedical, Inc., (VASO) announced that the patient enrollment target has been met in the PEECH (Prospective Evaluation of EECP in Congestive Heart Failure) trial, the company's pivotal clinical trial...

Acute coronary syndrome follows use of the symmetry bypass connector device.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Placement of the Symmetry Bypass Connector (St. Jude Medical, St. Paul, Minnesota) resulted in acute coronary syndrome and occluded saphenous vein grafts necessitating additional procedures in 5 of 121...

Study of adult stem cell reimplantation initiated.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- By harvesting and reimplanting a patient's own stem cells, physicians hope to grow new blood vessels to relieve the disabling chest pain of severely ill cardiac patients. Physicians at Caritas St....

Nucleic acid detection technology developer forms subsidiary.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Centrex, Inc., (CNEX) announced that to enhance the company's ability to accelerate the development of the company's Single Molecule Nucleic Acid Detection (SMD) technology, Centrex, Inc., in...

Gemini laser system launched.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Laserscope (LSCP) has introduced the Gemini Dual-Wavelength Laser System. The Gemini is currently cleared by the U.S. Food and Drug Adminstration (FDA) for 17 different clinical applications and is...

BCBS of Massachusetts expands capsule endoscopy reimbursement.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Given Imaging, Ltd., (GIVN) announced that Blue Cross and Blue Shield of Massachusetts has expanded its capsule endoscopy coverage policy to include initial diagnosis in patients with suspected Crohn...

Repaired sensing leads are as durable as new leads.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Researchers find that repairing broken implantable defibrillator leads with a patch kit is as durable as replacing the leads and may reduce morbidity and hospital stay. "Breaks in the insulation...

New laser therapy prevents acne from graduating to scars.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- What's a four-letter word for a skin condition that affects nearly 80% of the population in various forms and can cause considerable emotional stress? If you answered acne, then you hit this...

Patent granted for advanced insulin pump infusion sets.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- SpectRx, Inc. (SPRX) was granted a patent for its proprietary rotating hub connection and disconnect system for infusion sets used with insulin pumps and other medical devices. U.S. Patent No....

Human BioSystems signs exclusive sales agreement for MyoVision line.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Human BioSystems (HBSC), a biomedical company conducting research to extend the shelf life of blood platelets and donor organs, announced that it has signed an exclusive sales consulting agreement with...

DuPont fabrics used in new protective surgical apparel.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Medline Industries, Inc., has launched new single-use protective surgical apparel, featuring DuPont Medical Fabrics' composite technology. Medline's Aurora gown, the newest member of Medline's...

Fluidigm granted nonexclusive sublicense to nanovolume crystallization patents.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Fluidigm Corp. and Syrrx, Inc., announced that Fluidigm has obtained from Syrrx license rights directed to the submicroliter crystallization of proteins. The terms of the agreement were not...

Telepathology product installed for drug discovery and research.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Trestle Holdings Inc. (TLHO) has further expanded its relationship with Pfizer, Inc. (PFE) under which the company installed an additional MedMicro telepathology product at the Pfizer research center in...

Drugs-of-abuse testing products receive FDA clearance.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Varian, Inc., (VARI) announced that two of its latest rapid drugs-of-abuse testing products - OnTrak TesTcup II and OnSite CupKit - have received 510(k) clearance from the U.S. Food and Drug...

Parotid may be invaded by squamous cell external auditory canal carcinoma.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Parotid excision should be performed in patients with advanced squamous cell carcinoma of the external auditory canal. "Until now, little was known about the mode of parotid involvement in external...

SonoPrep skin permeation device receives FDA marketing clearance.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Sontra Medical Corporation (SONT) has received 510(k) marketing clearance from the U.S. Food and Drug Administration (FDA) to market the SonoPrep ultrasonic skin permeation device and electrode system...

Prolonged menstruation is associated with developing endometrial cancer.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Never having been pregnant, never having given birth, and longer menstruation were associated with an increased risks of developing endometrial cancer among women in Shanghai. According to a study...

Staging esophageal cancer with endoscopic MR imaging is safe.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- MR imaging to stage esophageal cancer is comparable to endoscopic ultrasound staging, but some overstaging occurred. "The authors defined esophageal anatomy and evaluated esophageal cancer staging...

FDA accepts filing for Sculptra.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Dermik Laboratories, the U.S. dermatology arm of Aventis (AVE), announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and granted expedited review of the company's Premarket...

Allograft implant processor announces 2003 financial results.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Regeneration Technologies, Inc., (RTI) the Florida-based processor of orthopedic, cardiovascular and other allograft implants, announced that the company's net revenues were $75.5 million for the full...

Anal fissure drug maker announces investment by SJ Strategic Investments.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Cellegy Pharmaceuticals, Inc., (CLGY) announced that SJ Strategic Investments has increased its ownership position in Cellegy to 29.1%. SJ Strategic Investments is a family investment vehicle owned...

Bioanalytical measurement systems-maker meets guidance.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Molecular Devices Corp. (MDCC) announced its revenues and earnings for the quarter and year ended December 31, 2003. Revenues and earnings per share for the quarter and year were within...

Biotech company increases share capital as a result of employee warrants.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Genmab A/S announced that it is increasing its share capital by 183,500 shares as a consequence of the exercise of employee warrants. This increase is effected without any preemption rights for the...

Cachexia drug developer secures $12M in financing.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that it entered into an agreement with James Dicke II and his son James Dicke III whereby ADVR shall sell to the two purchasers an aggregate of 120,000,000...

Cardiac device company reports first profitable quarter.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Endocardial Solutions, Inc., (ECSI) reported net sales for the fiscal year ended December 31, 2003, of $36.6 million, compared with $26.3 million for fiscal year ended December 31, 2002, an increase of...

Developer of proteomics-based diagnostic products reports increased revenues.
March 7, 2004... 2004 MAR 7 - (NewsRx.com & NewsRx.net) -- Matritech (MZT), a developer of proteomics-based diagnostic products for the early detection of cancer, reported financial results for the fourth quarter and the year ended December 31, 2003. "This...